Rilonacept Articles
New study highlights changes in the management of gout and hyperuricemia among US rheumatologists and PCPs
2 March 2010
Regeneron initiates Ph III Arcalyst study
27 March 2009
Arcalyst reduces gout flares 81% in Ph II trial
15 September 2008
Thomson releases Pharma Matters reports for 1st qtr
1 September 2008
US FDA set for even fewer approvals in 2008
1 September 2008
Regeneron's Arcalyst available in USA
31 March 2008
FDA clears Regeneron's Arcalyst
10 March 2008
Regeneron's CAPS drug cleared by FDA
3 March 2008
Showing 1-11 of 11 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
